Literature DB >> 11471763

Sleep disorders.

M H Silber1.   

Abstract

Many pharmacologic and nonpharmacologic strategies are available to treat sleep disorders successfully. Conventional stimulants and the new stimulant modafinil have roles to play in the management of narcolepsy and idiopathic hypersomnia. Knowledge of the properties and clinical effects of these drugs allows adequate doses of medications to be used with the goal of attaining as maximal alertness as possible. A range of dopaminergic agents is available to treat restless legs syndrome; other medications such as opiates, benzodiazepines, and anticonvulsants can also be used. Successful use of the dopaminergic agents depends on an understanding of the phenomena of augmentation, rebound, and tolerance. Arousal parasomnias can be treated with behavioral methods such as hypnosis and drug therapy. Clonazepam provides relief of the symptoms in most patients with REM sleep behavior disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11471763     DOI: 10.1016/s0733-8619(05)70011-6

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  4 in total

1.  Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial.

Authors:  Arash Mowla; Laaya Ahmadzadeh; Leila Razeghian Jahromi; Seyed Ali Dastgheib
Journal:  Clin Drug Investig       Date:  2015-08       Impact factor: 2.859

2.  Excessive daytime sleepiness among depressed patients.

Authors:  Celestine Okorome Mume
Journal:  Libyan J Med       Date:  2010-01-07       Impact factor: 1.657

3.  Diagnosis and treatment of sleep disorders: a brief review for clinicians.

Authors:  Vivien C Abad; Christian Guilleminault
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

4.  Effects of Occupational Stress and Circadian CLOCK Gene Polymorphism on Sleep Quality of Oil Workers in Xinjiang, China.

Authors:  Li Ning; Lingyun Shi; Ning Tao; Rong Li; Ting Jiang; Jiwen Liu
Journal:  Med Sci Monit       Date:  2020-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.